Welcome to our dedicated page for American Fusion news (Ticker: AMFN), a resource for investors and traders seeking the latest updates and insights on American Fusion stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect American Fusion's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of American Fusion's position in the market.
American Fusion (OTC: AMFN) canceled 1,683,000,000 common shares and returned them to treasury pursuant to a final court order dated April 27, 2026. The company expects issued and outstanding shares to be approximately 1,316,801,029, a ~56% reduction, after transfer agent updates.
The company plans a possible OTCQB uplist as early as mid-May 2026, expects to file its Q1 2026 Form 10-Q reflecting merger-contributed intellectual property, and may issue 240,000,000 restricted affiliate shares related to the Kepler transaction.
American Fusion (OTC: AMFN) announced placement in an AINewsWire editorial on April 24, 2026, highlighting energy constraints as a growing limit on AI expansion. The piece frames data centers as rising power consumers and describes AMFN's focus on aneutronic fusion and related supply chain work toward scalable energy systems for AI workloads.
American Fusion (OTC: AMFN) is expanding its Texatron™ intellectual property program, with approximately 280 patent filings in progress and an objective to pursue about 300 additional filings targeting reactor design, plasma behavior, energy conversion, and system integration.
The company plans to reflect IP contributed in the Feb 27, 2026 merger in its upcoming Q1 2026 Form 10-Q and has engaged an advisor to pursue a potential dual listing on the Frankfurt Stock Exchange; litigation in the Delaware Court of Chancery remains pending.
American Fusion (OTC: AMFN) was featured in an AINewsWire editorial on April 22, 2026 about energy limits for AI growth. The piece highlights the rising electricity demand of hyperscale data centers and positions American Fusion's focus on aneutronic fusion and supply-chain development as a potential path to scalable, high-efficiency energy systems.
The company says its work targets infrastructure capable of supporting AI-driven workloads as the sector shifts from theory toward deployable energy solutions.
American Fusion (OTC: AMFN) engaged Samuel Reid as Government Strategy and Procurement Advisor to pursue non-dilutive government funding, institutional contracts, and defense procurement channels. The company said it will align its platform with U.S. DOE programs, defense research channels, and European fusion initiatives while advancing program partnerships.
The company also filed an opening brief in a Delaware motion to dismiss and is implementing an ordered share cancellation in a Washington matter, expecting record updates in the normal course.
American Fusion (OTC: AMFN) reported participation at the ARPA-E Energy Innovation Summit 2026, where executives and technical leaders presented the Texatron™ fusion roadmap, met U.S. government labs and Navy representatives, and advanced commercialization and supply-chain planning.
The company refined near-term commercial focus on data center and behind-the-meter power use cases, explored helium-3 and deuterium sourcing, and is evaluating a potential dual listing in Frankfurt to strengthen European partnerships.
American Fusion (OTC: AMFN) says it is in final discussions to secure multi-year supply contracts for helium-3 and deuterium to fuel its Texatron aneutronic fusion system, aiming to reduce long-term operational uncertainty and support commercialization.
The company also reported recent Delaware Court of Chancery rulings denying expedited relief, filed a motion for injunctive relief on April 1, and expects court-ordered share cancellations to be reflected in its records.
American Fusion (OTC: AMFN) obtained a court order cancelling 1,683,000,000 improperly issued common shares, a move the company says removes more than half of outstanding stock and restores its capitalization table. The court entered the order in March 2026, and the company expects transfer-agent records updated before quarter-end.
Additional milestones: completion of a two-year PCAOB audit, a Feb 27, 2026 business combination with Kepler Fusion Technologies, a Form 10 filing expected to become effective on May 14, 2026, and planned 10-Q filing by May 15, 2026.
American Fusion (OTC: AMFN) received SEC notice that its Form 10-12G filed March 16, 2026, will receive a “no review” designation and is expected to become effective automatically on May 14, 2026. Upon effectiveness, the company will be subject to full Exchange Act reporting, including Form 10-Q and 10-K obligations.
The company expects its first Form 10-Q for the quarter ended March 31, 2026, to reflect the February share-exchange merger and newly acquired technology and IP, and views SEC reporting as a step toward OTCQB uplisting and potential Form 211 sponsorship while engaging investment banks for capital and listing advice.
American Fusion (OTC: AMFN) provided an update on industry engagements on March 24, 2026. Representatives are attending IWAHLM-17 in Bergamo, Italy (March 24–26) and APEC in San Antonio, Texas (March 22–26). The company said these activities support technical networking, monitoring adjacent technologies, and relationship-building.